Targeting peroxiredoxins against leukemia

Experimental Cell Research

Volumn 319, Issue 2, 2013, Pages 170-176

  Liu, Chuan Xu ^a   Zhou, Hu Chen ^b   Yin, Qian Qian ^c   Wu, Ying Li ^a   Chen, Guo Qiang ^a,c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adenanthin; Differentiation; Diterpenoid; Leukemia; Peroxiredoxins

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; DITERPENOID; PEROXIDASE; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 4; PEROXIREDOXIN 5; PEROXIREDOXIN 6; REACTIVE OXYGEN METABOLITE;

ACUTE LEUKEMIA; APOPTOSIS; AUTOPHAGY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME TRANSLOCATION; HUMAN; IC 50; IN VITRO STUDY; LEUKEMIA; M PHASE CELL CYCLE CHECKPOINT; MITOSIS INHIBITION; PRIORITY JOURNAL; QUANTUM YIELD; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; ZINC FINGER MOTIF;

EID: 84870734794     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.06.013     Document Type: Review

References (42)

1. Bae Y.S., Oh H., Rhee S.G., Yoo Y.D. Regulation of reactive oxygen species generation in cell signaling. Mol. Cells 2011, 32:491-509.
2. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signalling 2012, 24:981-990.
3. Dickinson B.C., Chang C.J. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 2011, 7:504-511.
4. Liu C.X., Yin Q.Q., Zhou H.C., Wu Y.L., Pu J.X., Xia L., Liu W., Huang X., Jiang T., Wu M.X., He L.C., Zhao Y.X., Wang X.L., Xiao W.L., Chen H.Z., Zhao Q., Zhou A.W., Wang L.S., Sun H.D., Chen G.Q. Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. Nat. Chem. Biol. 2012, 8:486-493.
5. Huang M.E., Ye Y.C., Chen S.R., Chai J.R., Lu J.X., Zhao L., Gu L.J., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988, 72:567-572.
6. Zhou G.B., Kang H., Wang L., Gao L., Liu P., Xie J., Zhang F.X., Weng X.Q., Shen Z.X., Chen J., Gu L.J., Yan M., Zhang D.E., Chen S.J., Wang Z.Y., Chen Z. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood 2007, 109:3441-3450.
7. Xu H.Z., Huang Y., Wu Y.L., Zhao Y., Xiao W.L., Lin Q.S., Sun H.D., Dai W., Chen G.Q. Pharicin A, a novel natural ent-kaurene diterpenoid, induces mitotic arrest and mitotic catastrophe of cancer cells by interfering with BubR1 function. Cell Cycle 2010, 9:2897-2907.
8. Gu Z.M., Wu Y.L., Zhou M.Y., Liu C.X., Xu H.Z., Yan H., Zhao Y., Huang Y., Sun H.D., Chen G.Q. Pharicin B stabilizes retinoic acid receptor-alpha and presents synergistic differentiation induction with ATRA in myeloid leukemic cells. Blood 2010, 116:5289-5297.
9. Guibal F.C., Alberich-Jorda M., Hirai H., Ebralidze A., Levantini E., Di Ruscio A., Zhang P., Santana-Lemos B.A., Neuberg D., Wagers A.J., Rego E.M., Tenen D.G. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 2009, 114:5415-5425.
10. Tothova Z., Gilliland D.G. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 2007, 1:140-152.
11. Owusu-Ansah E., Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009, 461:537-541.
12. Callens C., Coulon S., Naudin J., Radford-Weiss I., Boissel N., Raffoux E., Wang P.H., Agarwal S., Tamouza H., Paubelle E., Asnafi V., Ribeil J.A., Dessen P., Canioni D., Chandesris O., Rubio M.T., Beaumont C., Benhamou M., Dombret H., Macintyre E., Monteiro R.C., Moura I.C., Hermine O. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J. Exp. Med. 2010, 207:731-750.
13. 2, and protein chaperones. Antioxid. Redox Signaling 2011, 15:781-794.
14. Lopez-Pedrera C., Villalba J.M., Siendones E., Barbarroja N., Gomez-Diaz C., Rodriguez-Ariza A., Buendia P., Torres A., Velasco F. Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets. Proteomics 2006, 6 (Suppl. 1):S293-299.
15. Palande K.K., Beekman R., van der Meeren L.E., Beverloo H.B., Valk P.J., Touw I.P. The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. PLoS One 2011, 6:e16340.
16. Kang S.W., Rhee S.G., Chang T.S., Jeong W., Choi M.H. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 2005, 11:571-578.
17. Zhang B., Wang Y., Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett. 2009, 286:154-160.
18. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997, 89:3354-3360.
19. Wang Z.Y., Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008, 111:2505-2515.
20. Brown D., Kogan S., Lagasse E., Weissman I., Alcalay M., Pelicci P.G., Atwater S., Bishop J.M., PMLRARalpha A. transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 1997, 94:2551-2556.
21. Kogan S.C., Hong S.H., Shultz D.B., Privalsky M.L., Bishop J.M. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 2000, 95:1541-1550.
22. 3 exerts dose-dependent dual effects on APL cells. Blood 1997, 89:3345-3353.
23. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 1996, 88:1052-1061.
24. Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B., Liang W.X., Song A.X., Lallemand-Breitenbach V., Jeanne M., Zhang Q.Y., Yang H.Y., Huang Q.H., Zhou G.B., Tong J.H., Zhang Y., Wu J.H., Hu H.Y., de The H., Chen S.J., Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010, 328:240-243.
25. Raelson J.V., Nervi C., Rosenauer A., Benedetti L., Monczak Y., Pearson M., Pelicci P.G., Miller W.H. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 1996, 88:2826-2832.
26. Huang Y., Zhao Q., Zhou C.X., Gu Z.M., Li D., Xu H.Z., Wiedmer T., Sims P.J., Zhao K.W., Chen G.Q. Antileukemic roles of human phospholipid scramblase 1 gene, evidence from inducible PLSCR1-expressing leukemic cells. Oncogene 2006, 25:6618-6627.
27. Zhao K.W., Li X., Zhao Q., Huang Y., Li D., Peng Z.G., Shen W.Z., Zhao J., Zhou Q., Chen Z., Sims P.J., Wiedmer T., Chen G.Q. Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 2004, 104:3731-3738.
28. Huang Y., Du K.M., Xue Z.H., Yan H., Li D., Liu W., Chen Z., Zhao Q., Tong J.H., Zhu Y.S., Chen G.Q. Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha. Leukemia 2003, 17:2065-2073.
29. Liu W., Guo M., Xu Y.B., Li D., Zhou Z.N., Wu Y.L., Chen Z., Kogan S.C., Chen G.Q. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood 2006, 107:698-707.
30. Titov D.V., Gilman B., He Q.L., Bhat S., Low W.K., Dang Y., Smeaton M., Demain A.L., Miller P.S., Kugel J.F., Goodrich J.A., Liu J.O. XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nat. Chem. Biol. 2011, 7:182-188.
31. Loudet A., Burgess K. BODIPY dyes and their derivatives: syntheses and spectroscopic properties. Chem. Rev. 2007, 107:4891-4932.
32. Wu S.F., Huang Y., Hou J.K., Yuan T.T., Zhou C.X., Zhang J., Chen G.Q. The downregulation of onzin expression by PKCepsilon-ERK2 signaling and its potential role in AML cell differentiation. Leukemia 2010, 24:544-551.
33. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood 1997, 90:489-519.
34. Friedman A.D. Transcriptional regulation of granulocyte and monocyte development. Oncogene 2002, 21:3377-3390.
35. Nagamura-Inoue T., Tamura T., Ozato K. Transcription factors that regulate growth and differentiation of myeloid cells. Int. Rev. Immunol. 2001, 20:83-105.
36. Lawless M.W., O'Byrne K.J., Gray S.G. Targeting oxidative stress in cancer. Expert Opin. Ther. Targets 2010, 14:1225-1245.
37. Raj L., Ide T., Gurkar A.U., Foley M., Schenone M., Li X., Tolliday N.J., Golub T.R., Carr S.A., Shamji A.F., Stern A.M., Mandinova A., Schreiber S.L., Lee S.W. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
38. Singh J., Petter R.C., Baillie T.A., Whitty A. The resurgence of covalent drugs. Nat. Rev. Drug Discovery 2011, 10:307-317.
39. Yamamoto T., Sakaguchi N., Hachiya M., Nakayama F., Yamakawa M., Akashi M. Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger. Leukemia 2009, 23:761-769.
40. Lu Y., Xu Y.B., Yuan T.T., Song M.G., Lubbert M., Fliegauf M., Chen G.Q. Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis. Leukemia 2006, 20:987-993.
41. Lu Y., Peng Z.G., Yuan T.T., Yin Q.Q., Xia L., Chen G.Q. Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity. Leukemia 2008, 22:378-386.
42. Zhen T., Wu C.F., Liu P., Wu H.Y., Zhou G.B., Lu Y., Liu J.X., Liang Y., Li K.K., Wang Y.Y., Xie Y.Y., He M.M., Cao H.M., Zhang W.N., Chen L.M., Petrie K., Chen S.J., Chen Z. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein. Sci. Transl. Med. 2012, 4:127-138.